Velpatasvir
Velpatasvir (GS-5816) is a second generation, pan-genotypic inhibitor of HCV NS5A, demonstrates a high barrier to resistance in HCV replicon assays.HCV Infection Phase 3 Clinical.
Product Specifications
CAS Number
1377049-84-7
Product Name Alternative
GS-5816 | GS 5816 | GS5816
Field of Research
Pharmacology & Drug Discovery
Purity
>98% (HPLC)
Solubility
DMSO: 146.66 mg/mL (Need ultrasonic and warming)
Smiles
O=C (OC) N[C@H] (C1=CC=CC=C1) C (N2[C@H] (C3=NC=C (C4=CC5=C (C6=CC7=CC=C8C (NC ([C@H]9N (C ([C@H] (C (C) C) NC (OC) =O) =O) [C@@H] (C) CC9) =N8) =C7C=C6OC5) C=C4) N3) C[C@H] (COC) C2) =O
Molecular Formula
C49H54N8O8
Molecular Weight
883.0018
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
Carbamic acid, N-[ (1R) -2-[ (2S,4S) -2-[5-[1,11-dihydro-2-[ (2S,5S) -1-[ (2S) -2-[ (methoxycarbonyl) amino]-3-methyl-1-oxobutyl]-5-methyl-2-pyrrolidinyl][2]benzopyrano[4',3':6,7]naphth[1,2-d]imidazol-9-yl]-1H-imidazol-2-yl]-4- (methoxymethyl) -1-pyrrolidinyl]-2-oxo-
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
